Fiera Capital (Canada)
ACAD icon

Fiera Capital (Canada)’s Acadia Pharmaceuticals ACAD Stock Holding History

Fiera Capital (Canada)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-134,501
Closed -$3.75M – 656
2017
Q2 		$3.75M Sell
134,501
-17,868
-12% -$532K 0.02% 335
2017
Q1 		$5.24M Sell
152,369
-8,335
-5% -$294K 0.03% 298
2016
Q4 		$4.63M Sell
160,704
-27,398
-15% -$725K 0.03% 340
2016
Q3 		$5.98M Sell
188,102
-5,371
-3% -$182K 0.03% 292
2016
Q2 		$6.28M Buy
+193,473
New +$6.47M 0.04% 285

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fiera Capital (Canada)'s ACAD Position: Q3 2017 in Review

Fiera Capital (Canada) sold out of Acadia Pharmaceuticals (ACAD) in Q3 2017, closing a stake of 134,501 shares — an estimated $3.75M sold.

Fiera Capital (Canada) first reported a position in ACAD in Q2 2016 and held it in 5 quarters. The position peaked at $6.28M in Q2 2016. 212 funds tracked by Wall St. Rank hold ACAD as of Q3 2017.

  • Fiera Capital (Canada) reported no remaining Acadia Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 134,501 Acadia Pharmaceuticals shares in Q3 2017, an estimated $3.75M.
  • Fiera Capital (Canada) first reported a position in Acadia Pharmaceuticals in Q2 2016 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Acadia Pharmaceuticals position peaked at $6.28M in Q2 2016.
  • 212 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2017, filed 13 Nov 2017.